Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review

[1]  J. Cameron,et al.  Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2017, Annals of surgery.

[2]  Chen Wang,et al.  Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer , 2017, Scientific Reports.

[3]  Hongtu Zheng,et al.  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis , 2016, World Journal of Surgical Oncology.

[4]  Zhuang Yu,et al.  Prognostic significance of neutrophil-lymphocyteratio/platelet-lymphocyteratioin lung cancers: a meta-analysis , 2016, Oncotarget.

[5]  K. Schmetterer,et al.  Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer , 2016, Oncotarget.

[6]  K. Hirakawa,et al.  Platelet–Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer , 2016, PloS one.

[7]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2016, British Medical Journal.

[8]  N. Na,et al.  Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors , 2016, Oncotarget.

[9]  Wentao Yang,et al.  Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer , 2016, PloS one.

[10]  C. Gong,et al.  Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study , 2016, BMC Cancer.

[11]  Hua-min Zheng,et al.  A novel prognostic inflammation score predicts outcomes in patients with ovarian cancer. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[12]  Xintao Li,et al.  Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis , 2016, PloS one.

[13]  F. Ciardiello,et al.  Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis , 2016, ESMO Open.

[14]  A. Matsuda,et al.  Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis , 2016, Annals of Surgical Oncology.

[15]  Jeongseon Kim,et al.  Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis , 2015, Cancer Causes & Control.

[16]  W. Liang,et al.  Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients , 2015, Tumor Biology.

[17]  Ping Liu,et al.  Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer , 2015, Cancer Chemotherapy and Pharmacology.

[18]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[19]  Ben Tran,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[20]  D. Cramer,et al.  Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer. , 2014, Gynecologic oncology.

[21]  S. Tangjitgamol,et al.  Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer , 2012, Journal of gynecologic oncology.

[22]  Viren Asher,et al.  Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer , 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[23]  Thaovalai Thavaramara,et al.  Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. , 2011, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[24]  R. Ozols.  Ovarian Cancer: American Cancer Society Atlas of Clinical Oncology , 2003 .

[25]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[26]  Y. Miao,et al.  Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy. , 2016, Cancer biomarkers : section A of Disease markers.

[27]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[28]  Sung Hoon Kim,et al.  Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment , 2008, Cancer Immunology, Immunotherapy.

[29]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.